When to Choose AOD-9604: AOD-9604 is particularly well-suited for individuals seeking selective fat metabolism enhancement without broader hormonal changes, those who have not responded adequately to diet and exercise alone for stubborn fat reduction, individuals who cannot tolerate or are contraindicated for GLP-1 agonists or growth hormone, athletes needing body composition improvement without affecting glucose regulation or hormone levels, and those preferring a well-researched peptide with established safety data from clinical trials
0.1% w/v Citric acid
[DOI] [PubMed] [Google Scholar] [3].Lppenthin K, Esbensen BA, stergaard M
It has been shown that reducing VEGF levels by 50% significantly impairs the angiogenesis process
Among the GLP-1 RAs, evidence of CV benefit is strongest for liraglutide, favorable for semaglutide, and less certain for exenatide
Human medical use remains uncertain because BPC-157 lacks FDA approval, standardized dosing, and strong controlled clinical evidence
